In ND AML patients, we observed a significantly positive correlation between the levels of EZH2 and CDC20 (r = 0.3867, P = 0.0305) and of MAD2 and CDC20 (r = 0.38672, P = 0.0087) (Fig. 1I). The gene discussed is EZH2; the disease is acute myeloid leukemia.